Overview CR-CHOP+X in Previously Untreated DEL Status: RECRUITING Trial end date: 2028-12-01 Target enrollment: Participant gender: Summary This is a prospective, single-arm, open-label phase II clinical trial that evaluates the efficacy and safety of CR-CHOP regimen combined with different targeted drugs based on different molecular subtypes in newly diagnosed DEL patients.Phase: PHASE2 Details Lead Sponsor: Ruijin HospitalTreatments: Decitabineorelabrutinib